Multi-institutional analysis of pancreatic adenocarcinoma demonstrating the effect of diabetes status on survival after resection

HPB

Volumn 14, Issue 4, 2012, Pages 228-235

  Cannon, Robert M ^a   LeGrand, Ryan ^a   Chagpar, Ryaz B ^a   Ahmad, Syed A ^b   McClaine, Rebecca ^b   Kim, Hong Jin ^c   Rupp, Christopher ^c   Cho, Cliff S ^c   Brinkman, Adam ^d   Weber, Sharon ^d   Winslow, Emily R ^d   Kooby, David A ^e   Chu, Carrie K ^e   Staley, Charles A ^e   Glenn, Ian ^f   Hawkins, William G ^f   Parikh, Alexander A ^g   Merchant, Nipun B ^g   McMasters, Kelly M ^a   Martin, Robert C G ^a   Callender, Glenda G ^a   Scoggins, Charles R ^a   more..

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e EMORY UNIVERSITY   (United States)

^f WASHINGTON UNIVERSITY   (United States)

^g VANDERBILT UNIVERSITY   (United States)

Author keywords

Diabetes mellitus; Disease free survival; Lymph node ratio; Margin; Multivariable analysis; Prognostic factors; Prognostic nomogram

Indexed keywords

AGED; ARTICLE; BLOOD TRANSFUSION; CANCER SURVIVAL; DIABETES MELLITUS; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS FISTULA; PANCREAS RESECTION; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDY;

EID: 84862822934     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2011.00432.x     Document Type: Article

References (57)

1. Jemal A, Siegel R, Xu J, Ward E. (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277-300.
2. Geer RJ, Brennan MF. (1993) Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 165:68-72.
3. Katz MH, Wang H, Fleming JB, Sun CC, Hwang RF, Wolff RA et al. (2009) Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol 16:836-847.
4. Yeo CJ, Cameron JL, Lillemore KD, Sitzmann JV, Hruban RH, Goodman SN et al. (1995) Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg 221:721-731.
5. Benassai G, Mastrorilli M, Quarto G, Cappiello A, Giani U, Forestieri P et al. (2000) Factors influencing survival after resection for ductal adenocarcinoma of the head of the pancreas. J Surg Oncol 73:212-218. (Pubitemid 30238413)
6. Cleary SP, Gryfe R, Guindi M, Greig P, Smith L, Mackenzie R et al. (2004) Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. J Am Coll Surg 198:722-731. (Pubitemid 38542900)
7. Ferrone CR, Brennan MF, Gonen M, Coit DG, Fong Y, Chung S et al. (2008) Pancreatic adenocarcinoma: the actual 5-year survivors. J Gastrointest Surg 12:701-706.
8. Winter JM, Cameron JL, Campbell KA, Arnold MA, Chang DC, Coleman J et al. (2006) 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 10:1199-1210.
9. Yeo CJ, Cameron JL. (1998) Prognostic factors in ductal pancreatic cancer. Langenbecks Arch Surg 383:129-133. (Pubitemid 28442526)
10. Chu CK, Mazo AE, Goodman M, Egnatashvili V, Sarmiento JM, Staley CA et al. (2010) Preoperative diabetes mellitus and long-term survival after resection of pancreatic adenocarcinoma. Ann Surg Oncol 17:502-513.
11. Fleming JB, Gonzalez RJ, Petzel MQ, Lin E, Morris JS, Gomez H et al. (2009) Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma. Arch Surg 144:216-221.
12. Sperti C, Pasquali C, Piccoli A, Pedrazzoli S. (1996) Survival after resection for ductal adenocarcinoma of the pancreas. Br J Surg 83:625-631. (Pubitemid 26163547)
13. Tsai S, Choti MA, Assumpcao L, Cameron JL, Gleisner AL, Herman JM et al. (2010) Impact of obesity on perioperative outcomes and survival following pancreaticoduodenectomy for pancreatic cancer: a large single-institution study. J Gastrointest Surg 14:1143-1150.
14. Benns M, Woodall C, Scoggins C, McMasters K, Martin R. (2009) The impact of obesity on outcomes following pancreatectomy for malignancy. Ann Surg Oncol 16:2565-2569.
15. Bentrem DJ, Yeh JJ, Brennan MF, Kiran R, Pastores SM, Halpern NA et al. (2005) Predictors of intensive care unit admission and related outcome for patients after pancreaticoduodenectomy. J Gastrointest Surg 9:1307-1312. (Pubitemid 41751124)
16. House MG, Fong Y, Arnaoutakis DJ, Sharma R, Winston CB, Protic M et al. (2008) Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. J Gastrointest Surg 12:270-278.
17. Mullen JT, Davenport DL, Hutter MM, Hosokawa PW, Henderson WG, Khuri SF et al. (2008) Impact of body mass index on perioperative outcomes in patients undergoing major intra-abdominal cancer surgery. Ann Surg Oncol 15:2164-2172.
18. Noun R, Riachy E, Ghorra C, Yazbeck T, Tohme C, Abboud B et al. (2008) The impact of obesity on surgical outcome after pancreaticoduodenectomy. JOP 9:468-476.
19. Williams TK, Rosato EL, Kennedy EP, Chojnacki KA, Andrel J, Hyslop T et al. (2009) Impact of obesity on perioperative morbidity and mortality after pancreaticoduodenectomy. J Am Coll Surg 208:210-217.
20. Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL et al. (2008) Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 300:2754-2764.
21. van de Poll-Franse LV, Houterman S, Janssen-Heijnen ML, Dercksen MW, Coebergh JW, Haak HR. (2007) Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer 120:1986-1992.
22. Wang F, Herrington M, Larsson J, Permert J. (2003) The relationship between diabetes and pancreatic cancer. Mol Cancer 2:4-9.
23. Batty GD, Kivimaki M, Morrison D, Huxley R, Smith GD, Clarke R et al. (2009) Risk factors for pancreatic cancer mortality: extended follow-up of the original Whitehall Study. Cancer Epidemiol Biomarkers Prev 18:673-675.
24. Chari ST, Leibson CL, Rabe KG, Timmons LJ, Ransom J, de Andrade M et al. (2008) Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 134:95-101. (Pubitemid 350309328)
25. Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, Barzi F, Woodward M. (2005) Type-II diabetes and pancreatic cancer: a metaanalysis of 36 studies. Br J Cancer 92:2076-2083.
26. Pannala R, Leirness JB, Bamlet WR, Basu A, Petersen GM, Chari ST. (2008) Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology 134:981-987. (Pubitemid 351451984)
27. Pannala R, Basu A, Petersen GM, Chari ST. (2009) New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol 10:88-95.
28. Chu CK, Mazo AE, Sarmiento JM, Staley CA, Adsay NV, Umpierrez GE et al. (2010) Impact of diabetes mellitus on perioperative outcomes after resection for pancreatic adenocarcinoma. J Am Coll Surg 210:463-473.
29. Mathur A, Zyromski NJ, Pitt HA, Al-Azzawi H, Walker JJ, Saxena R et al. (2009) Pancreatic steatosis promotes dissemination and lethality of pancreatic cancer. J Am Coll Surg 208:989-994.
30. Souza JJ, Machado MC, Cunha JE, Jukemura J, Nery M, Wajchenberg BL et al. (2007) Analysis of pancreatic adenocarcinoma tumor staging and resection according to previous body mass index and diabetes duration. Pancreatology 7:187-193. (Pubitemid 47094089)
31. Cameron JL, Riall TS, Coleman J, Belcher KA. (2006) One thousand consecutive pancreaticoduodenectomies. Ann Surg 244:10-15. (Pubitemid 44297442)
32. Fatima J, Schnelldorfer T, Barton J, Wood CM, Wiste HJ, Smyrk TC et al. (2010) Pancreatoduodenectomy for ductal adenocarcinoma: implications of positive margin on survival. Arch Surg 145:167-172.
33. Howard TJ, Krug JE, Yu J, Zyromski NJ, Schmidt CM, Jacobson LE et al. (2006) A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer. J Gastrointest Surg 10:1338-1345.
34. Bassi C, Stocken DD, Olah A, Friess H, Buckels J, Hickey H et al. (2005) Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial. Dig Surg 22:353-363.
35. Butturini G, Stocken DD, Wente MN, Jeekel H, Klinkenbijl JH, Bakkevold KE et al. (2008) Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials. Arch Surg 143:75-83. (Pubitemid 351159303)
36. Hernandez J, Mullinax J, Clark W, Toomey P, Villadolid D, Morton C et al. (2009) Survival after pancreaticoduodenectomy is not improved by extending resections to achieve negative margins. Ann Surg 250:76-80.
37. Raut CP, Tseng JF, Sun CC, Wang H, Wolff RA, Crane CH et al. (2007) Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 246:52-60. (Pubitemid 47012207)
38. House MG, Gonen M, Jarnagin WR, D'Angelica M, DeMatteo RP, Fong Y et al. (2007) Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer. J Gastrointest Surg 11:1549-1555.
39. Schnelldorfer T, Ware AL, Sarr MG, Smyrk TC, Zhang L, Qin R et al. (2008) Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg 247:456-462.
40. Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, MacDonald JS et al. (2005) Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 23:8706-8712. (Pubitemid 46211514)
41. Inoue K, Nakane Y, Iiyama H, Sato M, Kanbara T, Nakai K et al. (2002) The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol 9:27-34. (Pubitemid 34262894)
42. Berger AC, Watson JC, Ross EA, Hoffman JP. (2004) The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg 70:235-240.
43. Bhatti I, Peacock O, Awan AK, Semeraro D, Larvin M, Hall RI. (2010) Lymph node ratio versus number of affected lymph nodes as predictors of survival for resected pancreatic adenocarcinoma. World J Surg 34:768-775.
44. Pawlik TM, Gleisner AL, Cameron JL, Winter JM, Assumpcao L, Lillemoe KD et al. (2007) Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery 141:610-618. (Pubitemid 46616937)
45. Riediger H, Keck T, Wellner U, zur Hausen A, Adam U, Hopt UT et al. (2009) The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. J Gastrointest Surg 13:1337-1344.
46. Slidell MB, Chang DC, Cameron JL, Wolfgang C, Herman JM, Schulick RD et al. (2008) Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis. Ann Surg Oncol 15:165-174.
47. Gonen M, Heller G. (2005) Concordance probability and discriminatory power in proportional hazards regression. Biometrika 92:965-970. (Pubitemid 41681247)
48. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. (eds) (2011) AJCC Cancer Staging Manual, 7th edn. New York: Springer.
49. Brennan MF, Kattan MW, Klimstra D, Conlon K. (2004) Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg 240:293-298. (Pubitemid 38963021)
50. Cheng Q, Zhang B, Zhang Y, Jiang X, Zhang B, Yi B et al. (2007) Predictive factors for complications after pancreaticoduodenectomy. J Surg Res 139:22-29. (Pubitemid 46482557)
51. Mathur A, Pitt HA, Marine M, Saxena R, Schmidt CM, Howard TJ et al. (2007) Fatty pancreas: a factor in postoperative pancreatic fistula. Ann Surg 246:1058-1064. (Pubitemid 350179200)
52. Park SM, Lim MK, Jung KW, Shin SA, Yoo KY, Yun YH et al. (2007) Prediagnosis smoking, obesity, insulin resistance, and second primary cancer in male cancer survivors: National Health Insurance Corporation Study. J Clin Oncol 25:4835-4843.
53. Dawson SI. (2004) Long-term risk of malignant neoplasm associated with gestational glucose intolerance. Cancer 100:149-155.
54. Lim JE, Chien MW, Earle CC. (2003) Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg 237:74-85. (Pubitemid 36622320)
55. Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA et al. (2000) Resected adenocarcinoma of the pancrease - 616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 4:567-579.
56. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H et al. (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350:1200-1210. (Pubitemid 38339364)
57. Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K et al. (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297:267-277. (Pubitemid 46143304)